Correlative results from NCI CTEP/ETCTN 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for advanced conventional chondrosarcoma (cCS).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kristine Peregrino Lacuna, Matthew Ingham, Li Chen, Biswajit Das, Shing M Lee, Liner Ge, Mihaela Druta, Anthony Paul Conley, Mary Louise Keohan, Mark Agulnik, Melissa Amber Burgess, Anna Weinberg Chalmers, Gina Z. D'Amato, Benjamin Powers, Mahesh Seetharam, Brittany L Siontis, Lorraine Cheryl Pelosof, Brian Andrew Van Tine, Gary K. Schwartz, Mia C. Weiss
Institutions: Columbia University Irving Medical Center, Frederick National Laboratory for Cancer Research, Columbia University, Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Huntsman Cancer Institute, University of Miami, Sylvester Comprehensive Cancer Center, University of Kansas Medical Center, Mayo Clinic Hospital, Mayo Clinic, National Cancer Institute, Washington University in St. Louis, Case Western Reserve University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399628965